Doxorubicin Hydrochloride
| Product Name | Doxorubicin Hydrochloride for Injection USP 50 mg |
| Brand Name | ------ |
| Composition | Doxorubicin Hydrochloride 50 mg Lactose Monohydrate 250 mg |
| Packing | 30 ml Vial |
| Available strength | 50 mg/ vial |
| Therapeutic use | -Antimitotic and cytotoxic. Doxorubicin has been used successfully to produce regression in a wide range of neoplastic conditions including acute leukaemia, lymphomas, soft-tissue and osteogenic sarcomas, paediatric malignancies and adult solid tumours; in particular breast and lung carcinomas. -Doxorubicin is frequently used in combination chemotherapy regimens with other cytotoxic drugs. Doxorubicin cannot be used as an antibacterial agent |